Repeat Laboratory Tests: Understanding Modifier 91 Boundaries

The direct answer: a repeat result is not always another service

Modifier 91 may be appropriate for a medically necessary repeat clinical diagnostic laboratory test performed on the same patient on the same day to obtain subsequent results during treatment. It is not a general duplicate-claim override. CMS's laboratory NCCI guidance excludes repeats performed to confirm initial results, address specimen or equipment problems, or obtain the single reportable result ordinarily required. It also cautions against using the modifier when another code describes the series of results. Start by determining why testing occurred again. The number of analyzer runs or instrument messages does not, by itself, establish the number of separately reportable services.

Separate clinical repetition from technical reruns

A clinically requested subsequent measurement answers a new question about the patient's condition during the course of care. A technical rerun may instead complete the laboratory's work toward one valid result. Document those activities differently in the laboratory system. Retain the treating clinician's order or other applicable support, collection and performance times, reported results, and the reason for subsequent testing. If a specimen problem causes recollection, do not assume recollection automatically creates another payable laboratory service. The relevant question is whether the record supports a distinct medically necessary test rather than the correction or completion of the original testing process.

Review series codes, units, and payer instructions

Before adding modifier 91, confirm that the selected code accurately represents the service and that a different code does not already describe the intended series. Review current coding instructions, applicable edits, units, and claim-line formatting. A modifier cannot make an unsupported unit count accurate. Distinguish repeat testing from duplicate claim transmission, which requires correction of the billing process rather than a clinical modifier. Where separate claim lines are appropriate, preserve the relationship between each line and its supporting event. Follow the payer's submission instructions without treating an electronic acceptance as proof that the service meets coverage or medical necessity requirements.

Hypothetical scenario: two repetitions with different purposes

A hypothetical laboratory performs a morning test and repeats the analysis because the instrument flags a technical concern. Only one finalized result is released from that work. Later, the treating clinician orders a subsequent measurement to assess the patient's response to treatment, and another specimen produces a separately reported result. The billing analyst distinguishes the technical rerun from the later clinical test. The first repetition does not become an additional service merely because it appears in the instrument log. The later event receives a separate coding and payer-rule review, including whether modifier 91 applies, supported by the order, timing, and clinical documentation.

Use an evidence-based repeat-test checklist

Repeat-test edits should route claims to a structured review, not automatically append a modifier. Ask whether the same patient and same-day circumstances fit the rule, whether each reported service has an appropriate clinical basis, and whether the record distinguishes technical work from subsequent testing. Compare order history, accession events, finalized results, and outbound claim lines. When information is unclear, request clarification from the appropriate clinical or laboratory owner. Record why the modifier was used or withheld. This allows future reviewers to evaluate the decision without reconstructing the entire instrument history or relying on an analyst's memory.

• Identify the purpose of every repeated test event.
• Exclude technical reruns and duplicate transmissions.
• Check whether another code describes the series.
• Match units and claim lines to supported services.
• Retain clinical and timing evidence for the decision.

Expect payer variation without inventing a repeat limit

Different payers may apply different submission requirements, coverage policies, and duplicate-service edits. Medicare NCCI guidance is not a universal commercial authorization policy. Verify the applicable product, service date, code instructions, and any relevant medical policy. Do not assume a fixed number of repeats is always payable, and do not describe modifier 91 as overriding frequency restrictions or medical necessity requirements. If a denial occurs despite supported clinical repetition, determine whether the problem concerns claim formatting, coding, coverage, or missing documentation. Select a correction or appeal based on that distinction rather than repeatedly resubmitting the same claim with additional modifiers.

Prevent technical activity from becoming duplicate charges

The most effective long-term control connects charge generation to reportable clinical events rather than every instrument transaction. Work with laboratory operations to distinguish quality-control activity, technical reruns, canceled work, and subsequent patient testing in the interface. Audit repeat-test claims against finalized results and order history, and investigate patterns tied to specific instruments or charge templates. Cyber Sense can help assess repeat-test billing edits, documentation routing, and denial follow-up for laboratory practices. Request a consultation to review how your system identifies repeated services and how staff decide whether the evidence supports modifier 91, another reporting approach, or no additional claim line.

Frequently asked questions

Related articles

• CLIA Number and Test Complexity: Laboratory Claim Checks Before Submission
• Laboratory Orders, Diagnosis, and Medical Necessity: Building a Supported Claim
• Laboratory ABN Workflow: Addressing Expected Medicare Noncoverage Before Testing